2024-05-02 08:05 | UU:SENS | | News Release200 | Senseonics Holdings, Inc. to Participate in Upcoming Conferences |
2024-04-30 16:05 | UU:SENS | | News Release200 | Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time |
2024-04-30 07:00 | UU:SENS | | News Release200 | Eversense(TM) CGM System Receives iCGM Designation by the US FDA |
2024-03-12 07:00 | UU:SENS | | News Release200 | SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS |
2024-03-08 08:05 | UU:SENS | | News Release200 | Senseonics Holdings, Inc. Announces Data From the Eversense(TM) Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes |
2024-02-29 16:05 | UU:SENS | | News Release200 | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results |
2024-02-15 16:05 | UU:SENS | | News Release200 | Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time |
2024-02-12 07:00 | UU:SENS | | News Release200 | Medicare Coverage Significantly Expanded for the Eversense E3 CGM System |
2024-02-12 07:00 | UU:SENS | | News Release200 | MEDICARE COVERAGE SIGNIFICANTLY EXPANDED FOR THE EVERSENSE E3 CGM SYSTEM |
2024-02-06 08:00 | UU:SENS | | News Release200 | PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care |
2024-01-02 16:05 | UU:SENS | | News Release200 | Senseonics Holdings, Inc. Announces Business Updates |
2023-11-09 16:05 | UU:SENS | | News Release200 | Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results |
2023-11-09 08:05 | UU:SENS | | News Release200 | Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare Conference |
2023-10-30 16:05 | UU:SENS | | News Release200 | Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern Time |
2023-10-09 07:00 | UU:SENS | | News Release200 | Ascensia Diabetes Care and Senseonics Announce ¢ € ˜The CGM for Real Life ¢ € ™ Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes |
2023-09-26 08:05 | UU:SENS | | News Release200 | Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study |
2023-09-14 08:05 | UU:SENS | | News Release200 | Senseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase |
2023-09-11 08:05 | UU:SENS | | News Release200 | Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital |
2023-08-10 16:15 | UU:SENS | | News Release200 | Senseonics Holdings, Inc. Reports Second Quarter 2023 Financial Results |
2023-07-27 16:05 | UU:SENS | | News Release200 | Senseonics Holdings, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 10, 2023 at 4:30 p.m. Eastern Time |
2023-07-05 16:05 | UU:SENS | | News Release200 | Senseonics Announces Equity Grants To Employees Under Inducement Plan |
2023-06-26 07:30 | UU:SENS | | News Release200 | New Clinical Data Demonstrating the Safety and Accuracy of Eversense through 365 Days Presented at the American Diabetes Association 83rd Scientific Sessions |
2023-06-02 07:00 | UU:SENS | | News Release200 | Senseonics Announces UnitedHealthcare Coverage of Eversense ‚ ® E3 CGM for Adults with Diabetes |
2023-05-26 07:00 | UU:SENS | | News Release200 | Senseonics to Participate in the Jefferies Healthcare Conference |
2023-05-09 16:05 | UU:SENS | | News Release200 | Senseonics Holdings, Inc. Reports First Quarter 2023 Financial Results |